DAA139 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
Molecular |
brain |
Human |
MLC1 |
10.0% Increase Gene Expression Level |
|
DAA143 |
metallothionein 1E |
Molecular |
brain |
Human |
MT1E |
10.0% Increase Gene Expression Level |
|
DAA129 |
microtubule-associated protein 2 |
Molecular |
brain |
Human |
MAP2 |
20.0% Decrease Gene Expression Level |
|
DAA133 |
microtubule-associated protein tau |
Molecular |
brain |
Human |
MAPT |
14.0% Decrease Gene Expression Level |
|
DAA141 |
mitochondrial ribosomal protein L33 |
Molecular |
brain |
Human |
MRPL33 |
4.0% Decrease Gene Expression Level |
|
DAA142 |
mitochondrial ribosomal protein S12 |
Molecular |
brain |
Human |
MRPS12 |
5.0% Decrease Gene Expression Level |
|
DAA131 |
mitogen-activated protein kinase 1 |
Molecular |
brain |
Human |
MAPK1 |
17.0% Decrease Gene Expression Level |
|
DAA132 |
mitogen-activated protein kinase 9 |
Molecular |
brain |
Human |
MAPK9 |
15.0% Decrease Gene Expression Level |
|
DAA130 |
mitogen-activated protein kinase kinase 1 |
Molecular |
brain |
Human |
MAP2K1 |
7.0% Decrease Gene Expression Level |
|
DAA140 |
monocyte to macrophage differentiation-associated |
Molecular |
brain |
Human |
MMD |
7.0% Decrease Gene Expression Level |
|
DAA70 |
multiple EGF-like-domains 8 |
Molecular |
brain |
Human |
MEGF8 |
27.0% Decrease Gene Expression Level |
|
DAA134 |
muscleblind-like 2 (Drosophila) |
Molecular |
brain |
Human |
MBNL2 |
12.0% Decrease Gene Expression Level |
|
DAA145 |
myosin VI |
Molecular |
brain |
Human |
MYO6 |
18.0% Increase Gene Expression Level |
|
DAA144 |
myosin X |
Molecular |
brain |
Human |
MYO10 |
20.0% Increase Gene Expression Level |
|
DAA154 |
N-ethylmaleimide-sensitive factor |
Molecular |
brain |
Human |
NSF |
10.0% Decrease Gene Expression Level |
|
DAA146 |
N-ethylmaleimide-sensitive factor attachment protein, alpha |
Molecular |
brain |
Human |
NAPA |
13.0% Decrease Gene Expression Level |
|
DAA147 |
N-ethylmaleimide-sensitive factor attachment protein, gamma |
Molecular |
brain |
Human |
NAPG |
23.0% Decrease Gene Expression Level |
|
DAA153 |
neurexin 1 |
Molecular |
brain |
Human |
NRXN1 |
15.0% Decrease Gene Expression Level |
|
DAA148 |
neurocalcin delta |
Molecular |
brain |
Human |
NCALD |
9.0% Decrease Gene Expression Level |
|
DAA152 |
neurogranin (protein kinase C substrate, RC3) |
Molecular |
brain |
Human |
NRGN |
4.0% Decrease Gene Expression Level |
|
DAA155 |
neurotensin receptor 2 |
Molecular |
brain |
Human |
NTSR2 |
7.0% Increase Gene Expression Level |
|
DAA150 |
NIMA (never in mitosis gene a)-related kinase 7 |
Molecular |
brain |
Human |
NEK7 |
17.0% Increase Gene Expression Level |
|
DAA151 |
NK2 homeobox 2 |
Molecular |
brain |
Human |
NKX2-2 |
14.0% Increase Gene Expression Level |
|
DAA149 |
Norrie disease (pseudoglioma) |
Molecular |
brain |
Human |
NDP |
9.0% Increase Gene Expression Level |
|
DAA157 |
nuclear fragile X mental retardation protein interacting protein 1 |
Molecular |
brain |
Human |
NUFIP1 |
24.0% Decrease Gene Expression Level |
|